IP Library › Patent Application 63492692
Patent Application Provisional Small
App. No. 63/492,692 · Confirmation No. 5964

EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT

Applicant: InhibRx, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2024-09-20 PET.POA.WDRW Request for withdrawal as attorney or agent 3 View
2024-09-20 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-04-07 APP.FILE.REC Filing Receipt 3 View
2023-03-28 SPEC Specification — View
2023-03-28 DRW.SUPP Drawings-black and white line and/or other drawings — View
2023-03-28 PA.. Power of Attorney 2 View
2023-03-28 DRW.NONBW Drawings-other than black and white line drawings 5 View
2023-03-28 N417 Electronic Filing System Acknowledgment Receipt 3 View
2023-03-28 N417.PYMT Electronic Fee Payment 2 View
2023-03-28 SPEC Specification 26 View
2023-03-28 CLM Claims 4 View
2023-03-28 ABST Abstract 1 View
2023-03-28 ADS Application Data Sheet 8 View
2023-03-28 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/492,692
Filed
2023-03-28